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Abstract
Background/Aim. Meningococcal disease most often manifests
itself as meningitis or sepsis. During the course of these diseases,
other clinical events sometimes develop such as pneumonia, peri-
carditis, arthritis, and they are referred to as extrameningeal or
systemic manifestations of the meningococcal disease. The aim of
this study was to investigate the type and the incidence of par-
ticular extrameningeal/systemic manifestations among patients
with meningococcal meningitis and sepsis, including time of their
onset and the influence on the disease outcome. Methods. The
retrospective study of the medical records of 246 patients treated
for meningococcal disease over the 25-year period in the Institute
for Infectious and Tropical Diseases, Belgrade was conducted.
The patients, aged 3 months to 82 years both sexes, were divided
into two groups. Results. Out of 246 patients extramenin-
geal/systemic manifestations were found in 42 (17.1%) patients:
35 (14.2%) occurred during meningitis, and seven (2.8%) during
sepsis. Pulmonary manifestations (mostly pneumonia) were the
most prevalent, found in 12 (4.9%) patients, followed by heart in-
volvement in nine (3.6%) patients (mostly pericarditis, in seven or
2.8% patients). Various ophthalmic manifestations occurred in
seven (2.8%), arthritis in 4 (1.6%) and sinusitis in six (2.4%) pa-
tients. Otitis, multiple renal embolisms with hematuria, osteomye-
litis and thrombophlebitis were evidenced in one patient, each.
Most of the systemic manifestations (30 patients or 71.4%), de-
veloped within the initial three days of the disease (p < 0.01), sug-
gesting direct pathogenic mechanism induced by meningococci
per se, while only three (7.1%) developed after seven days, when
immune-mediated disease was more likely. Even though these
manifestations complicate and prolong treatment of the menin-
gococcal disease, they had no major influence on the disease out-
come. Lethal outcome occurred in 2 (4.76%) patients, both with
the meningococcal type of the disease. Conclusion. Extramenin-
geal or systemic manifestations are uncommon complications
during the course of both meningococcal meningitis and sepsis.
The onset of pneumonia, pericarditis, eye involvement, and ar-
thritis, within the initial seven days of the disease, were most
prevalent in the course of meningitis. They had no major influ-
ence on the disease outcome.
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Apstrakt
Uvod/Cilj. Meningokokna bolest najčešće se manifestuje
kao meningitis ili sepsa. U toku ovih bolesti ponekad se raz-
viju i neke druge kliničke manifestacije, takođe izazvane
meningokokom, kao što su pneumonija, perikarditis, artritis
i one se nazivaju ekstrameningealne ili sistemske manifesta-
cije. Cilj rada bio je ispitivanje tipa i incidencije ekstrame-
ningealnih ili sistemskih manifestacija među bolesnicima sa
meningokoknim meningitisom i sepsom, i utvrđivanje vre-
mena njihovog nastanka i njihovog uticaja na ishod bolesti.
Metode. Urađena je retrospektivna studija medicinske do-
kumentacije 246 bolesnika lečenih od meningokokne bolesti
u toku 25 godina u Institutu za infektivne i tropske bolesti u
Beogradu. Rezultati. Od 246 bolesnika čija dokumentacija
je obrađena, ekstrameningealne ili sistemske manifestacije
registrovane su kod 42 (17,1%) bolesnika. Od toga, 35
(14,2%) nastalo je tokom meningitisa, a sedam (2,8%) za
vreme sepse. Plućne manifestacije, najčešće pneumonija,
nađene su kod 12 (4,9%) bolesnika, a zatim kardiološke kod
devet (3,6%) i to najčešće perikarditis (kod sedam ili 2,8%)
bolesnika. Različite oftalmološke manifestacije nađene su
kod sedam bolesnika (2,8%), artritis kod četiri (1,6%) i sinu-
zitisi kod šest (2,4%) bolesnika. Otitis, multiple bubrežne
embolije sa hematurijom, osteomijelitis i tromboflebitis na-
đeni su kod po jednog bolesnika. Najveći broj sistemskih
manifestacija, 30 ili 71,4% nastao je u prva tri dana bolesti
(p < 0,01), što govori u prilog direktnom dejstvu meningo-
koka, dok su samo tri (7,1%), nastale posle sedam dana, ka-
da se mogu pretpostaviti imunološki posredovani mehaniz-
mi bolesti. Mada su ove manifestacije komplikovale i pro-
dužile lečenje od meningokokne bolesti, one nisu značajnije
uticale na ishod bolesti. Letalni ishod nastupio je kod 2
bolesnika sa meningitisom (4,7%). Zaključak. Ekstrame-
ningealne ili sistemske manifestacije su retke komplikacije u
toku meningokoknog meningitisa i sepse. Nastanak pneu-
monije, perikarditisa, očnih manifestacija i atrtritisa najčešće
se registruje u toku prvih sedam dana bolesti, češće u toku
menigitisa i ne utiče na ishod bolesti.
Ključne reči:
meningitis, meningokokni; sepsa; pneumonija;
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Introduction
The term meningococcal disease includes different
clinical manifestations caused by Neisseria meningitidis. All
manifestations of the infection are based on penetration and
bloodborne dissemination of meningococcus, as well as on a
wide range of pathophysiological events triggered by the
bacterial endotoxin. The intensity of the inflammatory re-
sponse induced by the endotoxin generally determines se-
verity of the clinical presentation.
Meningococcal disease may present itself either as sep-
sis or meningitis. Transient meningococcemia, pharyngitis,
pneumonia, pericarditis, arthritis and conjunctivitis are only
infrequently diagnosed. These less frequent clinical condi-
tions may be the only manifestations of the meningococcal
disease, and in such cases the etiology may remain uncon-
firmed due to rapid recovery after favorable response to em-
piric antibiotic therapy. When these manifestations develop
in the course of meningitis, they are referred to as extrame-
ningeal, and systemic if in the course of sepsis.
Extrameningeal or systemic manifestations of the me-
ningococcal disease most frequently occur in the early phase
of the disease, which indicates that they develop as a direct
consequence of meningococcal dissemination. Less com-
monly, they develop in the later phase, frequently at the very
end of the antibiotic treatment, which is indicative of the
immune-mediated nature of the event.
Extrameningeal or systemic manifestations most com-
monly involve the lungs, heart, joints and eyes. They prolong
and complicate the treatment and may sometimes influence
the outcome of the disease.
The aim of this retrospective study was to investigate
the prevalence of extrameningeal and/or systemic manifesta-
tions among the patients with meningococcal meningitis and
sepsis, as well as the time of their onset and influence on the
course and outcome of the disease.
Methods
Medical records of patients treated for meningococcal
disease at the Institute of Infectious and Tropical Diseases in
Belgrade over the period 1979–2004 were analyzed.
The analysis included 246 patients of various ages (3
months to 82 years) and both sexes.
The patients were divided into two groups:
Group 1 – Meningitic type of the disease characterized
by typical symptoms and signs, along with signs of inflamma-
tion in the cerebrospinal fluid (CSF), including pleocytosis of
100–2 000 polymorphonuclear leukocytes per cubic millimeter,
low glycorrhachia and increased proteinorrhachia.
Group 2 – Septic type of the disease characterized by
the presence of septic manifestations accompanied by exces-
sive skin changes, without meningeal irritation and scarce
CSF pathology (<  100 polymorphonuclear leukocytes per
cubic millimeter, along with normal both glycorrhachia and
proteinorrhachia).
At the beginning of the study period both pediatric and
adult patients were included (patients age ranged from less
than a year to over 80). Over the last 10 years, due to the re-
organization of the pediatric service, we treated adult pa-
tients mostly.
The diagnosis of meningococcal disease was estab-
lished by isolation of meningococci from the blood and/or
CSF. Newer diagnostic techniques, such as polymerase chain
reaction (PCR) were not available. Serotyping was not per-
formed in all the cases, but serotype B prevailed, followed by
serotypes C and A.
Diagnosis of extrameningeal and systemic manifesta-
tions was based on standard clinical diagnostic methods
(chest X-ray, ECG, echosonography, pericardiocentesis if
required, ophthalmological examination, etc).
All statistical analyses were performed using the elec-
tronic database organized in the SPSS (version 11.5) statisti-
cal package. The Chi-square test was used to assess the
prevalence of certain extrameningeal and/or systemic mani-
festations of meningococcal disease in the meningitis versus
septic group.
Results
The study series involved the total of 246 patients. Out
of these, 211 (85.8%) had meningitis, while 35 (14.2%) were
diagnosed with the sepsis.
Systemic manifestations were evidenced in 42 (17.1%)
patients, out of which 35 (14.2%) and seven (2.8%) had
meningitis and sepsis respectively. These manifestations
were more frequent among patients with meningitis, but the
difference did not reach the level of statistical significance
(p > 0.05).
Among extrameningeal manifestations the most com-
mon were pulmonary, recorded in 12 (4.9%) patients, fol-
lowed by cardiac in nine (3.6%), ophthalmic in seven
(2.8%), articular in four (1.6%), maxillary sinusitis in six
(2.4%), while otitis media, multiple renal embolisms with
hematuria, osteomyelitis and thrombophlebitis were found in
one (0.4%) patient each (Table 1).
The distribution of particular extrameningeal/systemic
events did not differ among meningitis versus septic patients.
Pneumonia was the most prevalent pulmonary mani-
festation (ten patients) and most frequently found in the
meningitis group (9/10 patients, p < 0.05) (Table 1).
Pericarditis was the most common cardiac manifesta-
tion (7/9 patients) and it was more frequent in the patients
with meningitis (Table 1).
Ocular and auricular manifestations were recorded in
seven and in four patients, respectively (Table 1).
Most of the systemic manifestations, 30 (71.4%), de-
veloped within the first three days of the disease, nine
(21.4%) within 3–7 days, while only three (7.1%) developed
after seven days. Difference between early onset (1–3 days)
and late (>  7 days) reached the level of statistical signifi-
cance (p < 0.01) (Table 2).
 The average duration of treatment was eight days for
the meningitis in comparison to 10 days for sepsis (p > 0.01).
The treatment was significantly longer (15 days) in the group
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The total number of lethal outcomes among the patients
affected with meningococcal disease was 13 (5%), being
higher among the patients with the septic type of the disease.
Among patients with extrameningeal manifestations (n = 42)
the outcome of the disease was favorable in 40 patients
(95.2%), while 2 (4.76%) patients died (pneumonia and
thrombophlebitis), both from the meningitis group.
Discussion
In the course of the meningococcal sepsis and meningi-
tis, in addition to clinical manifestations typical for the dis-
ease, other extra-meningeal/systemic clinical conditions may
develop, as well. In our series of patients, they developed in
17%. Etiology of the manifestations may be verified by iso-
lation of meningococci and/or detection of the meningococ-
cal DNA, however these tests are often negative since antibi-
otic therapy has already been initiated.
Regarding pulmonary manifestations, pneumonia was
most frequently described, primarily in the elderly
 1, 2. It was
also most common in our patients (4.1%), almost exclusively
in those with meningitis (9 of 10). Pneumonia occurring in
the course of the meningococcal disease may be induced by
the meningococci per se or by some other organisms (due to
aspiration during the course of meningitis). If the nasopha-
ryngeal carriage of meningococci is present, identification of
Table 1
Type and frequency of  extrameningeal/systemic manifestations in the course of meningococcal disease
Extrameningeal/systemic complications [n(%)] Type of complications
Patients with meningitis
(n = 211)
Patients with septics
(n = 35)
Total
(n = 246)
Pulmonary 11 (5.2) 1 (2.8) 12 (4.9)
pneumonia 9 (4.3)* 1 (2.8) 10 (4.1)
bronchitis 1 (0.5) 1 (0.4)
atelectasis 1 (0.5) 1 (0.4)
Cardiac 7 (3.3) 2 (5.7) 9 (3.6)
pericarditis 5 (2.3) 2 (5.7) 7 (2.8)
transitory nodal rhythm 1 (0.5) 1 (0.4)
wandering pacemaker 1 (0.5) 1 (0.4)
Ophtalmic 6 (2.8) 1 (2.8) 7 (2.8)
optic nerve papilitis 1 (0.5) 1 (2.8) 2 (0.8)
epipapillary hemorrhage 1 (0.5) 1 (0.4)
papillary edema 2 (0.9) 2 (0.8)
conjunctivitis 2 (0.9) 2 (0.8)
Articular 3 (1.4) 1 (2.8) 4 (1.6)
arthritis of the knee 3 (1.4) 3 (1.2)
arthritis of the ankle 1 (2.8) 1 (0.4)
Maxillary sinusitis 6 (2.8) 6 (2.4)
Otitis media 1 (0.5) 1 (0.4)
Renal 1 (2.8) 1 (0.4)
Osteomyelitis 1 (2.8) 1 (0.4)
Thrombophlebitis 1 (0.5) 1 (0.4)
Total 35 (16.6) 7 (20) 42 (17.1)
* p < 0.05 vs patients with sepsis
Table 2
Time of onset of 42 extrameningeal/systemic manifestations during the course of menigococcal disease
 Number of patietns (%) Extrameningeal / Systemic manifestation
Day 1–3 Day 3–7 Day >7
Pneumonia 5 (11.9) 5 (11.9)
Atelectasis 1 (2.4)
Bronchitis 1 (2.4)
Pericarditis 6 (14.2) 1 (2.4)
Transitory nodal rhythm 1 (2.4)
Wandering pacemaker 1 (2.4)
Papillitis of the optic nerve 1 (2.4) 1 (2.4)
Epipapillary hemorrhage 1 (2.4)
Papillary edema 2 (4.7)
Conjunctivitis 2 (4.7)
Arthritis 2 (4.7) 1 (2.4) 1 (2.4)
Thrombophlebitis 1 (2.4)
Renal embolism with hematuria 1 (2.4)
Osteomyelitis 1 (2.4)
Otitis media 1 (2.4)
Sinusitis 1 (2.2)
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the disease etiology may be unreliable if based on the sputum
culture only, due to possible contamination of sputum sam-
ples. In our series, meningococci were isolated from the
blood cultures, and pneumonia resolved within seven days in
9/10 patients, suggesting meningococcal etiology.
One patient with pneumonia which developed on the
6th day of meningitis died.
Primary meningococcal pneumonia is rather uncommon
manifestation of the meningococcal disease. It develops most
commonly in the immunocompromised or elderly patients
 3.
In a study carried out in Finland, out of 182 patients with of
community-acquired pneumonia, meningococcus was proved
to be the causative organism in six cases only 
3. It may be
preceded by viral respiratory infections. Among the majority
of the elderly patients with meningococcal infections, Young
et al. 
4 reported serologic evidence of influenza.
Involvement of the paranasal sinuses and middle ear is
most probably a consequence of the meningococcal infection
per se, although the role of other bacteria cannot be ruled
out. Sinusitis was evidenced in six patients, while otitis and
lung atelectasis were found in one patient each (both with
impaired state of consciousness during meningitis).
  Cardiac manifestations most frequently described are
pericarditis and myocarditis, while in our patient series, con-
duction disorders (transitory nodal rhythm and wandering
pacemaker) were observed, as well.
Among patients with purulent pericarditis, meningo-
coccal etiology was confirmed in 6–16%
 5. The prevalence of
pericarditis of 2.8% in our series of patients is in concor-
dance with the data reported by Morse et al. 
6 and Pierce et
al. 
7 who recorded pericarditis prevalence of 3–19% among
patients with the meningococcal disease.
Finkelstein et al. 
5 proposed a classification of menin-
gococcal pericarditis into three groups: pericarditis as local
manifestation of the disseminated meningococcal disease;
isolated meningococcal pericarditis; and reactive (immune-
mediated) pericarditis.
Meningococcal pericarditis may be manifested as pu-
rulent or as serous. The difference is related to the time of its
onset. Purulent pericarditis develops during the early, bacte-
remic phase, while serous pericarditis develops later in the
course, even the convalescence phase (group three according
to Finkelstein 
5). It is believed that bacterial antigens due to
molecular mimicry lead to cross-reaction with the pericardial
antigens.
Various meningococcal serotypes were confirmed
among patients with pericarditis. It was observed that peri-
carditis developed more frequently in patients induced by se-
rotype C (61%); serotype B was found in two pediatric pa-
tients, while serotype W135 was recorded in four adult pa-
tients
 8, 9. However, other authors reported the highest num-
ber of pericarditis, arthritis and pneumonia cases in the
course of infections induced by serotype W135
 6, 7. In our se-
ries of patients there was no difference in the distribution of
meningococci serotypes regarding pericarditis. Clinical
manifestations of the disease may be obvious (chest pain,
dyspnea, pericardial friction rub). However, persistent fever
was occasionally the only clinical sign. ECG abnormalities
were found in all the patients, while the diagnosis was con-
firmed by echocardiography when available. Pericardial ef-
fusion evacuation is infrequently performed (due to small
amount), and thus isolation of the meningococci is excep-
tionally rare. If the amount of effusion is large enough it may
lead to cardiac tamponade, a life threatening condition
 7.
Fortunately, there were no cardiac tamponade cases in our
series.
In our series of patients, pericarditis was not associated
with any organ-specific symptoms, and the diagnosis was
established according to persistent fever and minimal peri-
cardial effusion on echosonography, both of which com-
pletely resolved after the conservative treatment with the
nonsteroidal anti-inflammatory drugs, while only one of
them received glucocorticoides.
Recurrent pericarditis is exceptionally rare after the
meningococcal infection. Several cases were described
among children, while the reasons of its recurrence most
commonly remain unknown
 10–12. The association with
chronic inflammatory diseases, cardiac surgeries, influenza
A infections or vaccinations was evidenced in some cases
 13.
In these cases, the course of the disease may be chronic and
unpredictable, regardless of the applied therapy or cause of
the relapse. It is known that corticosteroids lead to rapid
withdrawal of symptoms, however their administration may
also induce dependance
 14.
Based on the literature data, myocarditis of different
degree of severity is found in even 50% of patients who had
died from the meningococcal disease
 15. In a series of chil-
dren with meningococcemia, higher incidence of lethal out-
comes was observed in the group with echocardiographic
signs of the myocardial dysfunctions and well as signs of
myocardial ischemia with elevated values of creatine phos-
phokinase and troponin I
 16, 17. In our series of patients with
pericarditis two had ECG findings of myopericarditis, which
resolved after a day, but none of them had only myocarditis.
Congestive heart failure with pulmonary edema and
high central venous pressure accompanied by the signs of
poor peripheral perfusion were also described
 18.
Arthritis developing in the course of meningococcal
disease is uncommon occurring in 5–11% of patients
 19,  20.
Arthritis may develop early, during dissemination of menin-
gococci, or later, when immunological mechanisms are sup-
posed to be involved (synovial precipitation of immune
complexes). Jarret et al. 
20 reported arthritis in 10–20% of
patients, within 4–7 days from the onset of the disease. A
large joint (most frequently the knee) is most commonly af-
fected, while involvement of two or more large joints is less
common. Weisfelt et al.
 22 conducted a large national study to
investigate the prevalence of arthritis among patients suffer-
ing from bacterial meningitis and they found it to develop
most frequently in the course of meningococcal meningitis
(48/697, 12%). The knee was affected in 50%, without any
influence on favorable outcome of the disease or joint func-
tion.
Arthritis developed in four (1.6%) patients from our se-
ries and it affected one joint in each of them. In two patients,
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disease, while in one of the patients it developed after seven
days (suggesting the immune-mediated mechanism). Etiol-
ogy of the disease may be confirmed by isolation of menin-
gococci and/or detection of its DNA in the synovial fluid. In
our patients, diagnosis was based on the clinical criteria only.
Some authors reported arthritis to be significantly more fre-
quent in infection caused by the serotype W135
 6, 7.
Ophthalmic changes developing in the course of me-
ningococcal disease may be diverse. In addition to con-
junctivitis, which frequently accompanies numerous infec-
tious diseases, deeper structures of the eye may also be af-
fected. The most serious complication is endophthalmitis
that may lead to loss of vision
 23. In the pre-antibiotic era,
meningococcus was the most common cause of endoph-
thalmitis and it developed in 5% of patients 
24. In our series
ocular changes were found in seven (2.8%) and they devel-
oped most frequently within the first three days after the
onset of the disease, being more frequent among the pa-
tients with meningitis. Conjunctivitis and epipapillary
hemorrhage developed two days after the onset of the dis-
ease as a result of meningococcal dissemination. Papillary
edema and the optic nerve papillitis developed in the course
of meningitis due to the increased intracranial pressure. In
one of the patients, papillitis of the optic nerve developed
seven days after the onset of the disease, and thus, in addi-
tion to the infectious component the immune one may be
also considered in this case
 25.
Celulitis, adnexitis, sialoadenitis, upper respiratory tract
infections, genital and anal infections were also reported as
rare complications
 26.
In our series of patients, we have also found complica-
tions that had never been previously reported before. Multi-
ple renal embolisms with macroscopic hematuria associated
with sepsis is most probably induced by activation of the
vasoactive material due to edotoxemia. Osteomyelitis devel-
oped after extensive skin and soft tissue necrosis in a patient
suffering from meningococcal sepsis.
Most of the extrameningeal/systemic manifestations
developed within the first three days of the disease (71.4%)
which undoubtedly suggests a direct influence of meningo-
cocci. The proposed immune-mediated events associated
with meningococcal meningitis
 9 are observed in only 3
(7.1%) patients (seven days after the onset of meningitis),
such as papillitis of the optic nerve and arthritis cases.
Extrameningeal manifestations prolong and complicate
treatment of meningococcal disease. However they have no
significant influence on the outcome of the disease. Out of
42 patients, lethal outcome ensued in two (4.8%) – both from
the meningitis group. One of them had pneumonia, while the
other thrombophlebitis.
Conclusion
Extrameningeal or systemic manifestations are uncom-
mon complications during the course of both meningococcal
meningitis and sepsis. The onset of pneumonia, pericarditis,
eye involvement, and arthritis, as well as same rare compli-
cations, such as multiple renal embolism with hematuria
were observed within the initial seven days of the disease,
which indicates that they develop as a direct consequence of
meningococcal dissemination. They were more prevalent in
the course of meningitis, and they did not influence the dis-
ease outcome.
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